HomeProductsBioactive CompoundsAnti-Infective AgentsHCVTegobuvir
Chemical structure of CAS 1000787-75-6

Tegobuvir

CAS No.1000787-75-6
MDL No.MFCD18251457
MFC25H14F7N5
MW517.40
InChI KeyXBEQSQDCBSKCHJ-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1000787-75-6
Product NameTegobuvir

Associated Conditions

hepatitis C virus infection·chronic hepatitis C virus infection
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrug.

Antimicrobial agents and chemotherapy • Vol. 58, Issue 4 • 2014
PMID: 24419349PMC: PMC4023746DOI: 10.1128/AAC.02351-13

Imidazopyridazine hepatitis C virus polymerase inhibitors. Structure-activity relationship studies and the discovery of a novel, traceless prodrug mechanism.

Journal of medicinal chemistry • Vol. 57, Issue 5 • 2014
PMID: 24224729DOI: 10.1021/jm401337x

In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.

Antiviral research • Vol. 100, Issue 2 • 2013
PMID: 24013001DOI: 10.1016/j.antiviral.2013.08.018

The HCV non-nucleoside inhibitor Tegobuvir utilizes a novel mechanism of action to inhibit NS5B polymerase function.

PloS one • Vol. 7, Issue 6 • 2012
PMID: 22720059PMC: PMC3374789DOI: 10.1371/journal.pone.0039163

Documentation